ClinicalTrials.gg
CompletedNCT01295658Updated Jul 22, 2020

Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project

An observational study in Cancers, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-22.

Primary conditionBreast NeoplasmsRegistry: NeoplasmsReclassifiedWhy we changed it
Registry
Neoplasms — the first condition term the registry derived for this study.
ClinicalTrials.gg
Breast Neoplasms
Why
  1. The study's title name Breast Neoplasms, a narrower term within Neoplasms.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Cancer Support Community, Research and Training Institute, Philadelphia · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
3,729
Ages
18 Years and older
Sex
All
01

Study summary

Cancer Survivor Registry: The Breast Cancer M.A. P. (Mind Affects the Physical M.A.P.) Project to identify and help us understand the emotional and social needs of breast cancer survivors.

Read the detailed description

The Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project was the first registry of its kind to look at the emotional and social needs of individuals diagnosed with breast cancer and track how their needs changed throughout their cancer journey. Data will raise awareness and help develop programs to address the needs of breast cancer survivors. Findings from the Registry are disseminated online at www.CancerSupportCommunity.org/RegistryIndexReport2017

02

Conditions studied

  • Cancers

Browse trials for

Keywords

  • cancer
  • cancer survivorship
  • psychosocial needs
  • cancer experience
  • metastatic breast cancer
  • breast cancer
  • caregiver
03

In context

Breast Neoplasms Reclassified

14,843 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

This study's enrollment of 3,729 is above the median of 184 across 3,239 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Cancer Support Community, Research and Training Institute, Philadelphia is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Compared within Breast Neoplasms, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Neoplasms. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Any individual who has received a cancer diagnosis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having received a cancer diagnosis

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
3,729 participants (actual)
Patient registry
No

Groups and cohorts

  • Cancer Survivors

    This is a broad observational study conducted online at www.cancerexperienceregistry.org, or via pen and paper survey obtained by calling the cancer support helpline at 888-793-9355 Any individual who has ever received a cancer diagnosis, regardless of disease type, stage, treatment, and time since diagnosis, can take part in this study.

06

What researchers measure

Primary outcomes

  1. Self-reported quality of life measures

    Time frame: 4 weeks

07

Study locations

1 site
  • Cancer Support Community Research & Training Institute
    Philadelphia, Pennsylvania 19106, United States
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2010 to primary completion in Mar 2013, 34 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2011
First posted
Feb 14, 2011
StartActual
May 2010
Primary completionActual
Mar 2013
CompletionActual
Mar 2013
Last update
Jul 22, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01295658
Lead sponsor
Cancer Support Community, Research and Training Institute, Philadelphia
Responsible party
Elissa Kranzler, PhD (Director of Research, Cancer Support Community, Cancer Support Community, Research and Training Institute, Philadelphia) — Principal investigator
First posted
Feb 14, 2011
Start date
May 2010
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Jul 22, 2020

Study contacts

Linda House, RN, BSN, MSM
principal investigator · Cancer Support Community

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion